Study identifies possible COVID-19 drugs -- including several that are FDA-approved

Experimental therapy for parasitic heart disease may also help stop COVID-19

Significant decline in subarachnoid hemorrhage hospitalizations due to COVID-19

COVID-19 patients can be categorized into three groups